Treace Medical Concepts, Inc. Tax Withholding Paid on Stock Awards
Treace Medical Concepts, Inc. (TMCI) reported Tax Withholding Paid on Stock Awards of $233.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2026-08-07
- Treace Medical Concepts, Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2026-06-30 was $26.00K, a 85.71% increase year-over-year.
- Treace Medical Concepts, Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2026-03-31 was $207.00K, a 48.38% decline year-over-year.
- Treace Medical Concepts, Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-12-31 was $75.00K, a 141.94% increase year-over-year.
- Treace Medical Concepts, Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-09-30 was $412.00K.
- Treace Medical Concepts, Inc. payment, tax withholding, share-based payment arrangement for fiscal 2025 was $902.00K, a 236.57% increase from fiscal 2024.
- Treace Medical Concepts, Inc. payment, tax withholding, share-based payment arrangement for fiscal 2024 was $268.00K, a 1961.54% increase from fiscal 2023.
- Treace Medical Concepts, Inc. payment, tax withholding, share-based payment arrangement for fiscal 2023 was $13.00K.
- Treace Medical Concepts, Inc. payment, tax withholding, share-based payment arrangement for fiscal 2022 was $0.00.
| Period end | Payment, Tax Withholding, Share-based Payment Arrangement 3 month | Payment, Tax Withholding, Share-based Payment Arrangement 6 month | Payment, Tax Withholding, Share-based Payment Arrangement 9 month | Payment, Tax Withholding, Share-based Payment Arrangement 12 month |
|---|---|---|---|---|
| 2026-06-30 | $26.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $233.00K 10-Q · filed 2026-08-07 | $308.00K derived: sum of 3 quarters · filed 2026-08-07 | $720.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $207.00K 10-Q · filed 2026-05-08 | $282.00K derived: sum of 2 quarters · filed 2026-05-08 | $694.00K derived: sum of 3 quarters · filed 2026-05-08 | $708.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $75.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $487.00K derived: sum of 2 quarters · filed 2026-02-27 | $501.00K derived: sum of 3 quarters · filed 2026-08-07 | $902.00K 10-K · filed 2026-02-27 |
| 2025-09-30 | $412.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $426.00K derived: sum of 2 quarters · filed 2026-08-07 | $827.00K 10-Q · filed 2025-11-06 | $858.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $14.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $415.00K 10-Q · filed 2026-08-07 | $446.00K derived: sum of 3 quarters · filed 2026-08-07 | $446.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $401.00K 10-Q · filed 2026-05-08 | $432.00K derived: sum of 2 quarters · filed 2026-05-08 | $432.00K derived: sum of 3 quarters · filed 2026-05-08 | $432.00K derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $31.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $31.00K derived: sum of 2 quarters · filed 2026-02-27 | $31.00K derived: sum of 3 quarters · filed 2026-02-27 | $268.00K 10-K · filed 2026-02-27 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $0.00 derived: sum of 2 quarters · filed 2025-11-06 | $237.00K 10-Q · filed 2025-11-06 | $250.00K derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $237.00K 10-Q · filed 2025-08-07 | $250.00K derived: sum of 3 quarters · filed 2026-02-27 | $250.00K derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $237.00K 10-Q · filed 2025-05-08 | $250.00K derived: sum of 2 quarters · filed 2026-02-27 | $250.00K derived: sum of 3 quarters · filed 2026-02-27 | $250.00K derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $13.00K derived: sum of 2 quarters · filed 2026-02-27 | $13.00K derived: sum of 3 quarters · filed 2026-02-27 | $13.00K 10-K · filed 2026-02-27 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $0.00 derived: sum of 2 quarters · filed 2024-11-05 | $0.00 10-Q · filed 2024-11-05 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $0.00 10-Q · filed 2024-08-06 | ||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-07 | |||
| 2022-12-31 | $0.00 10-K · filed 2025-02-27 | |||
| 2021-12-31 | $0.00 10-K · filed 2024-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |